رجوع

Oscar Health, Inc.

جودة البيانات: 100%

OSCR

NYSE Healthcare Medical - Healthcare Plans

KWD 12.21

▼ KWD 0.42 (-3.33%)

القيمة السوقية: 3.17B

نطاق اليوم

KWD 12.12 KWD 12.85

نطاق 52 أسبوعًا

KWD 11.20 KWD 23.80

حجم التداول

9,437,594

متوسط 50 يوم / 200 يوم

KWD 14.26 / KWD 16.25

الإغلاق السابق

KWD 12.63

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس	السهم	وسيط القطاع
P/E	-7.1	0.4
P/B	3.2	2.9
ROE %	-44.5	3.8
Net Margin %	-3.8	3.9
Rev Growth 5Y %	57.1	10.0
D/E	0.4	0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة	تقدير ربحية السهم	تقدير الإيرادات	المحللون
FY2028	KWD 1.885 KWD 1.216 – KWD 2.314	22 B	3
FY2027	KWD 1.114 -KWD 0.105 – KWD 1.860	20 B	6
FY2026	KWD 0.378 -KWD 1.191 – KWD 1.399	19 B	5

النقاط الرئيسية

Revenue grew 57.10% annually over 5 years — strong growth

Earnings declined -1842.49% over the past year

Debt/Equity of 0.44 — conservative balance sheet

Generating 1.06B in free cash flow

PEG of 0.01 suggests growth is underpriced

Revenue growth is decelerating — 1Y growth trails 5Y average by 29.60%

النمو

Revenue Growth (5Y)

57.10%

Revenue (1Y)27.50%

Earnings (1Y)-1842.49%

FCF Growth (3Y)N/A

الجودة

Return on Equity

-44.51%

ROIC-21.12%

Net Margin-3.79%

Op. Margin-3.39%

الأمان

Debt / Equity

0.44

Current Ratio0.95

Interest Coverage-22.52

التقييم

P/E Ratio

-7.14

P/B Ratio3.24

EV/EBITDAN/A

Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y)	27.50%	Revenue Growth (3Y)	41.27%
Earnings Growth (1Y)	-1842.49%	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	57.10%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	11.70B	Net Income (TTM)	-443.15M
ROE	-44.51%	ROA	-7.01%
Gross Margin	14.38%	Operating Margin	-3.39%
Net Margin	-3.79%	Free Cash Flow (TTM)	1.06B
ROIC	-21.12%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	0.44	Current Ratio	0.95
Interest Coverage	-22.52	Dividend Yield	0.00%
Valuation
P/E Ratio	-7.14	P/B Ratio	3.24
P/S Ratio	0.27	PEG Ratio	0.01
EV/EBITDA	N/A	Dividend Yield	0.00%
Market Cap	3.17B	Enterprise Value	821.67M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	11.70B	9.18B	5.86B	4.13B	1.92B
Net Income	-443.15M	25.43M	-270.73M	-606.28M	-572.61M
EPS (Diluted)	-1.69	0.10	-1.22	-2.85	-3.19
Gross Profit	1.68B	1.84B	1.22B	4.13B	1.92B
Operating Income	-396.36M	57.27M	-235.62M	-610.08M	-570.58M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	6.33B	4.84B	3.60B	4.53B	3.32B
Total Liabilities	5.34B	3.82B	2.80B	3.63B	1.93B
Shareholders' Equity	977.65M	1.01B	803.97M	890.38M	1.39B
Total Debt	430.10M	299.56M	298.78M	298.00M	0.0
Cash & Equivalents	2.77B	1.53B	1.87B	1.56B	1.10B
Current Assets	4.61B	2.85B	2.07B	4.12B	2.77B
Current Liabilities	4.86B	3.17B	-175.28M	3.26B	1.62B

درجات الاستراتيجيات

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)

Rank = position among all matches

Growth Price/Sales Ratio Focus (Ken Fisher)

#107 of 616

Custom Full Throttle

#102 of 146

النشاط الأخير

دخل Price/Sales Ratio Focus (Ken Fisher)

Mar 24, 2026

دخل Full Throttle

Mar 24, 2026